Skip to content

Optimisation of research protocols for respiratory challenges with the RespirAct (RA-MR)TM in healthy volunteers

Optimisation of research protocols for respiratory challenges with the RespirAct (RA-MR)TM in healthy volunteers - RespirAct

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49452
Enrollment
80
Registered
2020-12-01
Start date
2021-10-14
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tissues and organs

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Signed informed consent - Age: 18-90 years - Healthy subject (defined as a volunteer who is not referred to Erasmus MC with signs and symptoms of disease)

Exclusion criteria

Exclusion criteria: - No informed consent - Subjects refusing to undergo testing - Subjects with obstructive or resistive lung disease whose PaCO2 at rest is greater than 50mmHg or whose venous serum bicarbonate is greater than 26 mEq/L - Subjects with pre-existing respiratory acidosis - Subjects who require portable oxygen at rest or with exercise - Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath - Subjects with severe heart failure or restrictive lung disease with resting respiratory rate over 15 breaths/min - Subjects with a typical contra-indication to an MRI exam - Subjects with metal implants - Woman who are pregnant or lactating - Having any physical or mental status that interferes with the informed consent procedure

Design outcomes

Primary

MeasureTime frame
Protocols for respiratory challenges will be optimised by trading off the duration and strength of respiratory stimulations with parameters of MRI quality to assess the vascular responses of interest (artefacts, signal to noise, contrast to noise, reproducibility, accuracy).

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)